LINCOLN NATIONAL CORP - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.

Quarter-by-quarter ownership
LINCOLN NATIONAL CORP ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$914,766
+3.2%
8,980
+2.2%
0.02%0.0%
Q2 2023$886,419
+19.0%
8,784
+8.5%
0.02%
+12.5%
Q1 2023$744,758
+0.9%
8,095
-0.5%
0.02%
-5.9%
Q4 2022$737,967
+39.8%
8,135
+17.2%
0.02%
+30.8%
Q3 2022$528,000
-7.0%
6,942
+3.4%
0.01%0.0%
Q2 2022$568,000
+15.2%
6,711
+19.5%
0.01%
+30.0%
Q1 2022$493,000
-5.2%
5,617
-5.5%
0.01%0.0%
Q4 2021$520,000
+6.6%
5,944
-0.3%
0.01%
-9.1%
Q3 2021$488,000
-30.2%
5,961
-22.2%
0.01%
-26.7%
Q2 2021$699,000
+17.9%
7,665
+10.4%
0.02%0.0%
Q1 2021$593,000
-6.5%
6,940
+3.4%
0.02%
-11.8%
Q4 2020$634,000
+6.2%
6,711
-2.3%
0.02%
-5.6%
Q3 2020$597,000
-17.9%
6,871
-17.5%
0.02%
-21.7%
Q2 2020$727,000
+6.8%
8,331
+0.9%
0.02%
-11.5%
Q1 2020$681,000
-18.1%
8,256
-6.1%
0.03%
-3.7%
Q4 2019$832,000
+107.5%
8,793
+90.3%
0.03%
+80.0%
Q3 2019$401,000
+79.0%
4,620
+88.6%
0.02%
+66.7%
Q2 2019$224,000
-6.7%
2,450
-1.9%
0.01%
-10.0%
Q1 2019$240,000
+5.3%
2,497
-6.2%
0.01%0.0%
Q4 2018$228,000
+3.2%
2,663
+3.7%
0.01%
+42.9%
Q3 2018$221,000
+7.3%
2,568
-5.8%
0.01%
-12.5%
Q2 2018$206,000
-29.5%
2,726
-24.6%
0.01%
-27.3%
Q1 2018$292,000
-52.1%
3,615
-50.2%
0.01%
-42.1%
Q4 2017$610,000
+108.9%
7,262
+113.3%
0.02%
+58.3%
Q3 2017$292,000
+15.4%
3,404
+11.9%
0.01%0.0%
Q2 2017$253,000
-86.2%
3,041
-87.9%
0.01%
-88.1%
Q4 2016$1,837,000
-2.9%
25,216
+5.3%
0.10%
-5.6%
Q3 2016$1,892,000
-1.5%
23,953
+3.0%
0.11%
-6.1%
Q2 2016$1,920,000
+5.0%
23,259
-7.9%
0.11%
-11.6%
Q1 2016$1,828,000
-1.9%
25,241
+10.5%
0.13%
-11.6%
Q4 2015$1,864,000
-8.3%
22,850
+4.9%
0.15%
-6.4%
Q3 2015$2,032,000
-9.8%
21,791
+2.6%
0.16%
-6.6%
Q2 2015$2,252,000
+9.8%
21,229
+2.0%
0.17%
+0.6%
Q1 2015$2,051,000
+12.9%
20,803
+6.1%
0.17%
+5.1%
Q4 2014$1,817,000
+0.6%
19,609
+2.2%
0.16%
-8.7%
Q3 2014$1,807,000
+12.1%
19,190
+7.7%
0.17%
+3.6%
Q2 2014$1,612,000
+7.0%
17,810
+0.5%
0.17%
-19.7%
Q1 2014$1,506,000
+11.7%
17,716
+5.5%
0.21%
+2.5%
Q4 2013$1,348,00016,7990.20%
Other shareholders
NOVARTIS A G shareholders Q4 2020
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders